AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 35 filers reported holding AGEX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,000 | -23.7% | 34,090 | -1.9% | 0.01% | -16.7% |
| Q4 2021 | $38,000 | +15.2% | 34,767 | -0.4% | 0.01% | +9.1% |
| Q3 2021 | $33,000 | -38.9% | 34,897 | 0.0% | 0.01% | -38.9% |
| Q2 2021 | $54,000 | -5.3% | 34,897 | 0.0% | 0.02% | -10.0% |
| Q1 2021 | $57,000 | +3.6% | 34,897 | -4.1% | 0.02% | -16.7% |
| Q4 2020 | $55,000 | +89.7% | 36,397 | +2.2% | 0.02% | +71.4% |
| Q3 2020 | $29,000 | -29.3% | 35,597 | -17.4% | 0.01% | -41.7% |
| Q2 2020 | $41,000 | -12.8% | 43,097 | -15.5% | 0.02% | -29.4% |
| Q1 2020 | $47,000 | -81.3% | 50,997 | -63.1% | 0.03% | -84.8% |
| Q4 2019 | $251,000 | -38.3% | 138,192 | -32.6% | 0.22% | -38.2% |
| Q3 2019 | $407,000 | -56.6% | 205,122 | -22.0% | 0.36% | -52.4% |
| Q2 2019 | $938,000 | -65.3% | 262,847 | -60.5% | 0.76% | -35.3% |
| Q1 2019 | $2,701,000 | +95.9% | 664,828 | +91.7% | 1.17% | -10.7% |
| Q4 2018 | $1,379,000 | – | 346,805 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 2,997,156 | $2,038,066 | 0.18% |
| Beirne Wealth Consulting Services, LLC | 18,000 | $16,077 | 0.01% |
| Strategic Wealth Investment Group, LLC | 92,603 | $62,970 | 0.01% |
| Prescott General Partners LLC | 185,185 | $125,926 | 0.01% |
| Summit X, LLC | 37,000 | $25,160 | 0.01% |
| Sigma Planning Corp | 181,385 | $123,342 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 144,770 | $98,444 | 0.00% |
| Piscataqua Savings Bank | 1,000 | $680 | 0.00% |
| UBS Group AG | 235 | $160 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 74 | $50 | 0.00% |